Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial.
Vermeulen EG, Rauwerda JA, van den Berg M, de Jong SC, Schalkwijk C, Twisk JW, Stehouwer CD. Vermeulen EG, et al. Among authors: rauwerda ja. Eur J Clin Invest. 2003 Mar;33(3):209-15. doi: 10.1046/j.1365-2362.2003.01135.x. Eur J Clin Invest. 2003. PMID: 12641538 Clinical Trial.
Hyperhomocysteinemia and atherothrombotic disease.
de Jong SC, van den Berg M, Rauwerda JA, Stehouwer CD. de Jong SC, et al. Among authors: rauwerda ja. Semin Thromb Hemost. 1998;24(4):381-5. doi: 10.1055/s-2007-996026. Semin Thromb Hemost. 1998. PMID: 9763355 Review.
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
de Jong SC, Stehouwer CD, van den Berg M, Geurts TW, Bouter LM, Rauwerda JA. de Jong SC, et al. Among authors: rauwerda ja. J Intern Med. 1999 Jul;246(1):87-96. doi: 10.1046/j.1365-2796.1999.00541.x. J Intern Med. 1999. PMID: 10447230 Free article.
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, van Campen CM, Visser FC, Jakobs CA, Bulterjis EJ, Rauwerda JA. Vermeulen EG, et al. Among authors: rauwerda ja. Lancet. 2000 Feb 12;355(9203):517-22. doi: 10.1016/s0140-6736(99)07391-2. Lancet. 2000. PMID: 10683000 Clinical Trial.
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study.
Vermeulen EG, Rauwerda JA, Erix P, de Jong SC, Twisk JW, Jakobs C, Witjes RJ, Stehouwer CD. Vermeulen EG, et al. Among authors: rauwerda ja. Neth J Med. 2000 Apr;56(4):138-46. doi: 10.1016/s0300-2977(00)00010-3. Neth J Med. 2000. PMID: 10727759
Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial.
van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. van Dijk RA, et al. Among authors: rauwerda ja. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2072-9. doi: 10.1161/hq1201.100223. Arterioscler Thromb Vasc Biol. 2001. PMID: 11742887 Clinical Trial.
Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial.
Vermeulen EG, Stehouwer CD, Valk J, van der Knaap M, van den Berg M, Twisk JW, Prevoo W, Rauwerda JA. Vermeulen EG, et al. Among authors: rauwerda ja. Eur J Clin Invest. 2004 Apr;34(4):256-61. doi: 10.1111/j.1365-2362.2004.01332.x. Eur J Clin Invest. 2004. PMID: 15086356 Clinical Trial.
166 results